ARCHIVES

DCT Board Questions Funding, Direction Of IL-2/LAK Trials

This article is from The Cancer Letter archive.

Vol. 15 No. 10 | March 3, 1989

Download PDF Visit The Full Archive

Related Articles

Docetaxel As Adjuvant Therapy Shows Benefit Over Standard

June 28, 2002

In Brief: Lou Carrese, NCI Associate Director, Dies; Myers, Ransahoff Head Two New Organ Systems Group

May 9, 1986

NCAB Disproves W. Virginia Construction Grant, Okays Funding Three New, Three Carryover Awards

May 24, 1985

Alan Rabson Named Acting NCI Director

October 5, 2001

NCI Tells How It Would Spend FY 1978 Research Money

June 25, 1976

Conversation with The Cancer Letter: Einhorn: “I Still Harbor Hope For Similar Success Stories”

October 24, 2014